Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 143, Issue 2, 2009, Pages 69-74

  Petru, Edgar ^a   Lück, Hans Joachim ^b   Stuart, Gavin ^c   Gaffney, David ^d   Millan, David ^e   Vergote, Ignace ^f  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cervical cancer; FIGO classification; FIGO staging; Ovarian cancer; Vulvar cancer

Indexed keywords

ARTICLE; ASCITES FLUID CYTOLOGY; BLADDER TUMOR; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; FERTILITY; GYNECOLOGIC CANCER; HIGH RISK PATIENT; HISTOLOGY; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE; LYMPH NODE DISSECTION; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PATIENT CODING; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM TUMOR; SCORING SYSTEM; TROPHOBLASTIC TUMOR; TUMOR VOLUME; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER; WORLD HEALTH ORGANIZATION;

EID: 61849143850     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.12.015     Document Type: Article

References (34)

1. Hertel H., Köhler C., Grund D., et al. Radical vaginal trachelectomy combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol 103 (2006) 506-511
2. Plante M., Renaud M., Francois H., and Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol 94 (2004) 614-623
3. Girardi F., Burghardt E., and Pickel H. Small FIGO stage IB cervical cancer. Gynecol Oncol 55 (1994) 427-432
4. Perez C., Grigsby P., Chao C., et al. Tumor size, irradiation dose, and long-term outcome of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 41 (1998) 307-310
5. Thoms W., Eifel P., Smith T., et al. Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 23 (1992) 491-499
6. Stehman F., Bundy B., DiSaia P., et al. Carcinoma of the cervix treated with radiation therapy I. Cancer 67 (1991) 2776-2785
7. Logsdon M., and Eifel P. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 43 (1999) 763-775
8. Lanciano R., Martz K., Coia L., and Hanks G. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Radiat Oncol Biol Phys 20 (1991) 95-100
9. Mariani A., Webb M., Keeney G., Aletti G., and Podratz K. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 86 (2002) 38-44
10. Kasamatsu T., Onda T., Katsamatu N., et al. Prognostic significance of peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 27 (2003) 245-250
11. Slomovitz B., Ramondetta L., Lee C., et al. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int. J. Gynecol Cancer 15 (2005) 510-516
12. Tebeu P., Popowski Y., Verkooijen H., et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br J Cancer 16 (2004) 720-724
13. Scholz H., Lax S., Petru E., Benedicic C., and Winter R. Inguinal lymph node metastasis as the presenting symptom of endometrial cancer: a case report. Anticancer Res 22 (2002) 2531-2532
14. Ramahi A., Malviya V., Ataya K., and Deppe G. Endometrial carcinoma presenting as a large inguinal mass. Int J Gynecol Obstet 28 (1989) 67-70
15. Creasman W., Odicino F., Maisonneuve, et al. Carcinoma of the corpus uteri. J Epidemiol Biostatist 6 (2001) 45-86
16. Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., and Vergote I. Endometrial Cancer. Lancet 366 (2005) 491-505
17. Kitchener H., Redman C., Swart A., and Amos C. ASTEC-a study in the treatment of endometrial cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol 101 (2006) S21-S22
18. Chan J., Loizzi V., Youssef M., et al. Significance of comprehensive surgical staging in non-invasive papillary serous carcinoma of the endometrium. Gynecol Oncol 90 (2003) 181-185
19. Podratz K., Mariani A., and Webb M. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 70 (1998) 163-164
20. Vergote I., De Brabanter J., Fyles A., et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357 (2001) 176-182
21. Trimbos J.B., Vergote I., Bolis G., et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-adjuvant chemotherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst 95 (2003) 113-125
22. Bertelsen K., Holund B., Andersen J., Nielsen K., Stroyer I., and Ladehoff P. Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int J Gynecol Cancer 3 (1993) 211-218
23. Sjövall K., Nilsson B., and Einhorn N. Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer 4 (1994) 333-336
24. Fader A., and Rose P. Role of surgery in ovarian carcinoma. J Clin Oncol 25 (2007) 2873-2883
25. Cliby W., Aletti G., Wilson T., and Podratz K. Is it justified to classify patients to stage IIIc epithelial ovarian cancer based on nodal involvement only?. Gynecol Oncol 103 (2006) 797-801
26. Petru E., Lahousen M., Tamussino K., et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170 (1994) 656-662
27. Aletti G., Dowdy S., Podratz K., and Cliby W. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol 105 (2007) 84-89
28. Benedet J., Turko M., Faiurey R., and Boyes D. Squamous carcinoma of the vulva: results of treatment, 1938 to 1976. Am J Obstet Gynecol 134 (1979) 201-207
29. Burger M., Hollema H., Emanuels A., Krans M., Pras E., and Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 57 (1995) 327-334
30. Homesley H., Bundy B., Sedlis A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival. Am J Obstet Gynecol 164 (1991) 997-1004
31. Moskovic E., Shepherd J., Barton D., Trott P., Nasiri N., and Thomas M. The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: a pilot study. Br J Obstet Gynaecol 106 (1999) 863-867
32. Hoffman M., DeCesare S., Roberts W., Fiorica J., Finan M., and Cavanagh D. Upper vaginectomy for in situ and occult superficially invasive carcinoma of the vagina. Am J Obstet Gynecol 166 (1992) 30-33
33. Eddy G., Singh K., and Gansler T. Superficially invasive carcinoma of the vagina following treatment for cervical cancer: a report of six cases. Gynecol Oncol 36 (1990) 376-379
34. Nghan N.Y.S. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer 14 (2004) 202-205